SCHEMBL8516472

SCHEMBL8516472

Nc1ccccc1C(=O)Nc1ccc2c(c1)CCCC2

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 9/20 0.67
RAB9A P51151 8/20 0.67
SMN1; SMN2 Q16637 4/20 0.67
NFKB1 P19838 4/20 0.67
NFKB2 Q00653 4/20 0.67
RELA Q04206 4/20 0.67
TP53 P04637 3/20 0.67
HTT P42858 3/20 0.67
MAPT P10636 2/20 0.67
MEN1 O00255 3/20 0.64
KMT2A Q03164 3/20 0.64
ATM Q13315 1/20 0.64
GAA P10253 1/20 0.61
RXFP1 Q9HBX9 1/20 0.56
FADS1 O60427 3/20 0.56
NPSR1 Q6W5P4 2/20 0.54
LMNA P02545 2/20 0.54
PKM P14618 1/20 0.53
STAT1 P42224 1/20 0.53
HSD17B10 Q99714 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8516647 0.97 NPC1 (0.71) NPC1RAB9ASMN1; SMN2NFKB1NFKB2
SCHEMBL9138988 0.80 NPC1 (0.71) NPC1RAB9ASMN1; SMN2NFKB1NFKB2
SCHEMBL9139676 0.80 NPC1 (0.71) NPC1RAB9ASMN1; SMN2NFKB1NFKB2
SCHEMBL17744848 0.79 PTGS1 (0.75) NPC1RAB9ASMN1; SMN2TP53HTT
SCHEMBL17744881 0.78 FADS1 (0.72) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL27600911 0.78 FADS1 (0.52) NPC1RAB9ASMN1; SMN2NFKB1NFKB2
SCHEMBL28708489 0.77 NPC1 (0.70) NPC1RAB9ASMN1; SMN2NFKB1NFKB2
SCHEMBL28715681 0.77 NPC1 (0.66) NPC1RAB9ASMN1; SMN2NFKB1NFKB2
SCHEMBL20303198 0.76 NPC1 (0.69) NPC1RAB9ASMN1; SMN2NFKB1NFKB2
SCHEMBL4957135 0.76 RAB9A (0.52) NPC1RAB9ASMN1; SMN2TP53MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1999052857-A1 NOVEL COMPOUNDS SMITHKLINE BEECHAM PLC (GB) 1999-10-21 WO disclosed